All B-ALL cells exhibited a dose-dependent reduction in viability, while t(9;22) CML cells were unaffected, corroborating our genetic data and consistent with a pan-B-ALL dependency on CBF activity (Fig. 8g). Here, CEBPZ is linked to chronic myelogenous leukemia, BCR-ABL1 positive.